Title:
FORMULATION CONTAINING HMGB1 PARTIAL PEPTIDE
Document Type and Number:
WIPO Patent Application WO/2021/215375
Kind Code:
A1
Abstract:
This pharmaceutical composition, which contains a substance described in any of the following (a) to (c), an organic acid, an organic acid metal salt, and a sugar and/or a sugar alcohol and which has a pH of 3.0-4.5 when dissolved in distilled water for injection, can stabilize the substance described in any of the following (a) to (c): (a) an HMGB1 fragment peptide that contains the amino acid sequence of SEQ ID NO: 1, or an acid addition salt of said peptide; (b) a peptide that contains the amino acid sequence of SEQ ID NO: 1, in which one or more amino acids have been replaced, deleted, inserted, or added, and that has activity to stimulate cell migration, or an acid addition salt of said peptide; and (c) a peptide that contains an amino acid sequence having a sequence identity of approximately 80% or more to the amino acid sequence of SEQ ID NO: 1 and that has activity to stimulate cell migration, or an acid addition salt of said peptide.
Inventors:
MATSUOKA NAO (JP)
HATANO SHUICHI (JP)
KUGA YUYA (JP)
OKABE MAKI (JP)
YAMAZAKI TAKEHIKO (JP)
YOKOTA KOICHI (JP)
HATANO SHUICHI (JP)
KUGA YUYA (JP)
OKABE MAKI (JP)
YAMAZAKI TAKEHIKO (JP)
YOKOTA KOICHI (JP)
Application Number:
PCT/JP2021/015792
Publication Date:
October 28, 2021
Filing Date:
April 19, 2021
Export Citation:
Assignee:
SHIONOGI & CO (JP)
STEMRIM INC (JP)
STEMRIM INC (JP)
International Classes:
A61K38/16; A61K9/08; A61K9/19; A61K47/02; A61K47/04; A61K47/12; A61K47/26; A61P43/00; C12N15/12
Domestic Patent References:
WO2014065347A1 | 2014-05-01 | |||
WO2019156137A1 | 2019-08-15 | |||
WO2012147470A1 | 2012-11-01 | |||
WO2014065347A1 | 2014-05-01 | |||
WO2008102849A1 | 2008-08-28 | |||
WO2013154045A1 | 2013-10-17 |
Foreign References:
JP2019189633A | 2019-10-31 | |||
JP2000169372A | 2000-06-20 |
Other References:
See also references of EP 4147711A4
Attorney, Agent or Firm:
SUGITA Ken-ichi et al. (JP)
Download PDF: